Literature DB >> 21924339

Using neural networks to determine the contribution of danshensu to its multiple cardiovascular activities in acute myocardial infarction rats.

Yuan-Cheng Chen1, Wan-Wen Cao, Yuan Cao, Lin Zhang, Bo-Bo Chang, Wen-Liang Yang, Xiao-Quan Liu.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Danshensu is an active water-soluble component from Salvia Miltiorrhiza, which has been demonstrated holding multiple mechanisms for the regulation of cardiovascular system. However, the relative contribution of danshensu to its multiple cardiovascular activities remains largely unknown. AIM OF THE STUDY: To develop an artificial neural network (NN) model simultaneously characterizing danshensu pharmacokinetics and multiple cardiovascular activities in acute myocardial infarction (AMI) rats. The relationship between danshensu pharmacokinetics (PK) and pharmacodynamics (PD) were evaluated using contribution values.
MATERIALS AND METHODS: Danshensu was intraperitoneally injected at a single dose of 20mg/kg to AMI rats induced by coronary artery ligation. Plasma levels of danshensu, cardiac troponin T (cTnT), total homocysteine (Hcy) and reduced glutathione (GSH) were quantified. A back-propagation NN model was developed to characterize the PK and PD profiles of danshensu, in which the input variables contained time, area under plasma concentration-time curve (AUC) of danshensu and rat weights (covariate). Relative contribution of input variable to the output neurons was evaluated using neuron connection weights according to Garson's algorithm. The kinetics of contribution values was also compared and was validated using bootstrap resampling method.
RESULTS: Danshensu exerted significant cTnT-lowering, Hcy- and GSH-elevating effect, and these marker profiles were well captured by the trained NN model. The calculation of relative contributions revealed that the effect of danshensu on the PD marker could be ranked as cTnT>GSH>Hcy, while the effect of AMI disease on the PD marker could be ranked in the following order: cTnT>Hcy>GSH. The activity of transsulfuration pathway was quite obvious under the AMI state.
CONCLUSION: NN is a powerful tool linking PK and PD profiles of danshensu with multiple cardioprotective mechanisms, it provides a simple method for identifying and ranking relative contribution to the multiple therapeutic effects of the drug. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924339     DOI: 10.1016/j.jep.2011.08.069

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  An Integrated Strategy to Identify and Quantify the Quality Markers of Xinkeshu Tablets Based on Spectrum-Effect Relationship, Network Pharmacology, Plasma Pharmacochemistry, and Pharmacodynamics of Zebrafish.

Authors:  Yongheng Wei; Lei Nie; Lele Gao; Liang Zhong; Zhongyu Sun; Xiangchun Yang; Jianan Yue; Yingzi Zeng; Lian Li; Jing Sun; Hengchang Zang
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 2.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

3.  Danshensu, a major water-soluble component of Salvia miltiorrhiza, enhances the radioresponse for Lewis Lung Carcinoma xenografts in mice.

Authors:  Hong-Ying Cao; Rui-Lin Ding; Meng Li; Mao-Nan Yang; Ling-Lin Yang; Jing-Bo Wu; Bo Yang; Jing Wang; Cui-Lian Luo; Qing-Lian Wen
Journal:  Oncol Lett       Date:  2016-12-16       Impact factor: 2.967

4.  Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.

Authors:  Ruiwen Wang; Zhecheng Wang; Ruimin Sun; Rong Fu; Yu Sun; Meiyang Zhu; Yunfei Geng; Dongyan Gao; Xiaofeng Tian; Yan Zhao; Jihong Yao
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

5.  Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation.

Authors:  Siyu Guo; Yingying Tan; Zhihong Huang; Yikui Li; Weiyu Liu; Xiaotian Fan; Jingyuan Zhang; Antony Stalin; Changgeng Fu; Zhishan Wu; Penglong Wang; Wei Zhou; Xinkui Liu; Chao Wu; Shanshan Jia; Jinyan Zhang; Xiaoxia Duan; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

6.  Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats.

Authors:  Hua Li; Yan-Hua Xie; Qian Yang; Si-Wang Wang; Bang-Le Zhang; Jian-Bo Wang; Wei Cao; Lin-Lin Bi; Ji-Yuan Sun; Shan Miao; Jing Hu; Xuan-Xuan Zhou; Peng-Cheng Qiu
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.